Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2024-12-16 Sale |
2024-12-17 6:03 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
430 | $0.35306 | $152 | 36,601 (Direct) |
View |
2024-10-03 Sale |
2024-10-03 9:54 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
7,175 | $0.55 | $3,946 | 28,278 (Direct) |
View |
2024-09-16 Sale |
2024-09-17 7:23 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
355 | $0.6893 | $245 | 22,955 (Direct) |
View |
2024-06-17 Sale |
2024-06-18 9:27 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
372 | $1.28 | $476 | 23,310 (Direct) |
View |
2024-04-04 Sale |
2024-04-08 7:30 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
1,067 | $2.635 | $2,812 | 23,682 (Direct) |
View |
2023-03-15 Sale |
2023-03-16 6:01 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
985 | $19.69 | $19,396 | 56,749 (Direct) |
View |
2023-01-20 Sale |
2023-01-24 8:08 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
50,000 | $30 | $1,500,000 | 8,397 (Direct) |
View |
2021-03-15 Sale |
2021-03-17 5:00 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $48.5 | $727,573 | 58,397 (Direct) |
View |
2021-02-16 Sale |
2021-02-18 4:56 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $57.68 | $865,153 | 73,397 (Direct) |
View |
2021-01-25 Sale |
2021-01-27 4:25 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $48.39 | $725,814 | 142,707 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2024-07-22 Option Award |
2025-04-01 6:02 pm |
N/A 2034-07-22 |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
1,875 | $0 | 1,875 (Direct) |
View |
2025-03-14 Exercise |
2025-03-17 6:36 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
65 | $0 | 2,489 (Direct) |
View |
2025-01-07 Option Award |
2025-01-10 8:01 pm |
N/A 2035-01-07 |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
270,000 | $0 | 270,000 (Direct) |
View |
2024-12-14 Exercise |
2024-12-17 6:03 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
1,083 | $0 | 36,601 (Direct) |
View |
2024-09-17 Option Award |
2024-10-03 9:54 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
21,250 | $0 | 28,278 (Direct) |
View |
2024-09-14 Exercise |
2024-09-17 7:23 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
1,084 | $0 | 22,955 (Direct) |
View |
2024-06-14 Exercise |
2024-06-18 9:27 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
1,083 | $0 | 23,310 (Direct) |
View |
2024-03-14 Exercise |
2024-04-08 7:30 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
2,771 | $0 | 23,682 (Direct) |
View |
2023-12-14 Exercise |
2023-12-18 4:57 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
521 | $0 | 15,749 (Direct) |
View |
2023-09-14 Exercise |
2023-09-18 4:49 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
521 | $0 | 15,749 (Direct) |
View |
2023-06-14 Exercise |
2023-06-16 6:44 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
521 | $0 | 15,749 (Direct) |
View |
2023-03-15 Option Award |
2023-03-16 6:01 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
41,000 | $0 | 56,749 (Direct) |
View |
2023-03-14 Exercise |
2023-03-16 6:01 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
2,084 | $0 | 56,749 (Direct) |
View |
2022-03-14 Option Award |
2022-03-16 4:15 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
41,687 | $0 | 41,687 (Direct) |
View |
2021-03-25 Option Award |
2021-03-29 8:49 pm |
N/A 2031-03-25 |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
22,000 | $0 | 22,000 (Direct) |
View |
2021-01-25 Exercise |
2021-01-27 4:25 pm |
N/A 2027-08-23 |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $0 | 142,707 (Direct) |
View |
2021-01-25 Exercise |
2021-01-27 4:25 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
15,000 | $0.41 | 142,707 (Direct) |
View |
2020-05-26 Option Award |
2020-05-28 4:16 pm |
N/A 2030-05-25 |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
45,000 | $0 | 45,000 (Direct) |
View |